Neochem Bio Solutions Makes Strong Market Debut at 10% Premium

Neochem Bio Solutions made an impressive debut on the stock market on December 9, listing at a 10.2% premium over its IPO price. The shares opened at ₹108 per share on the NSE SME platform, giving IPO investors an immediate 10% listing gain. Soon after listing, the stock moved up further to ₹111.20, a 2.96% rise from the opening price.

IPO Details and Fund Utilisation

The IPO was a ₹44.97 crore book-built issue, entirely fresh, consisting of 45.88 lakh new shares.

• Issue opened: December 2
• Closed: December 4
• Allotment: December 5
• Shares credited: December 8

The IPO was priced at an upper band of ₹98, valuing the company at ₹167.78 crore pre-issue. After the issue, the equity base expanded to 1.71 crore shares.

The company plans to use the funds for:

• ₹23.90 crore for long-term working capital
• ₹10 crore for loan repayment
• Remaining funds for general corporate purposes

Vivro Financial Services acted as the lead manager, MUFG Intime India Pvt. Ltd. as the registrar, and Rikhav Securities Ltd. as the market maker.

Strong Demand Across Investor Categories

The IPO saw excellent subscription, receiving bids 15.52 times the shares offered:

• QIBs: 21.97×
• NIIs: 21.15×
• Retail: 9.42×

Anchor investors invested ₹12.77 crore on December 1, picking up 13.03 lakh shares ahead of the issue.

Read More: Eternal CEO Deepinder Goyal Reveals ‘Temple’, a New Brain Blood Flow Monitoring Device.

About Neochem Bio Solutions

Neochem Bio Solutions is a specialty performance chemicals company offering 350+ customised formulations. Its products support several industries, including:

• Textiles & garments
• Home & personal care
• Industrial and institutional cleaning
• Water treatment
• Paints & coatings
• Construction
• Paper & pulp
• Rubber
• Dyes & pigments

Conclusion

Neochem Bio Solutions delivered a solid listing with a 10.2% premium, supported by strong IPO subscription and steady grey market signals. With its wide product portfolio and focus on essential industrial chemicals, the company enters the market on a strong footing, backed by robust investor interest.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.